Isomorphic Labs launches IsoDDE, an AI drug design engine that more than doubles AlphaFold 3's accuracy in predicting protein-ligand structures and binding affinities.
Eli Lilly, GSK, and Pfizer announce multi-year AI partnerships with startups Chai Discovery, Noetik, and Boltz for biologics design, cancer prediction, and drug discovery applications.
The pharmaceutical industry is poised for a paradigm shift from Research & Development (R&D) to Research & Prediction (R&P), with agentic AI expected to deliver the first fully predictive drug development pipeline by 2026.
Nvidia and pharmaceutical giant Eli Lilly establish co-innovation lab in San Francisco combining compute resources and scientific expertise to accelerate medicine development.
